SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parabolic Drugs - Quaterly Results

23 Oct 2020 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2020, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2020 is Rs. -72.20 millions as compared to Net Loss of Rs. -74.90 millions of corresponding quarter ended June 2019 Operating profit Margin for the quarter ended June 2020 improved to -17.10% as compared to -19.40% of corresponding quarter ended June 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 180.80 0.00
Other Income 0.00 0.10 0.00 0.00 0.10 0.00 0.20 8.00 -97.50
PBIDT -17.10 -19.40 -11.86 -17.10 -19.40 -11.86 -63.90 -139.50 -54.19
Interest 1.70 1.60 6.25 1.70 1.60 6.25 6.60 34.60 -80.92
PBDT -18.80 -21.00 -10.48 -18.80 -21.00 -10.48 -70.50 -192.90 -63.45
Depreciation 53.40 55.60 -3.96 53.40 55.60 -3.96 215.90 225.20 -4.13
PBT -72.20 -76.60 -5.74 -72.20 -76.60 -5.74 -286.40 -418.10 -31.50
TAX 0.00 -1.70 0.00 0.00 -1.70 0.00 0.00 -4.10 0.00
Deferred Tax 0.00 -1.70 0.00 0.00 -1.70 0.00 0.00 -4.10 0.00
PAT -72.20 -74.90 -3.60 -72.20 -74.90 -3.60 -286.40 -414.00 -30.82
Equity 618.90 618.90 0.00 618.90 618.90 0.00 618.90 618.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -77.16 0.00

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×